The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2seventy bio, Inc. | COM | 901384107 | 9,790,302 | 2,497,526 | SH | SOLE | 2,497,526 | 0 | 0 | |||
Aadi Bioscience, Inc. | COM | 00032Q104 | 4,791,252 | 989,928 | SH | SOLE | 989,928 | 0 | 0 | |||
AbCellera Biologics Inc. | COM | 00288U106 | 95,511,286 | 20,763,323 | SH | SOLE | 20,763,323 | 0 | 0 | |||
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 893,298,514 | 42,864,612 | SH | SOLE | 42,864,612 | 0 | 0 | |||
Achilles Therapeutics plc | SPONSORED ADS | 00449L102 | 2,326,750 | 2,557,149 | SH | SOLE | 2,557,149 | 0 | 0 | |||
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 8,556,040 | 10,969,282 | SH | SOLE | 10,969,282 | 0 | 0 | |||
Aerovate Therapeutics, Inc. | COM | 008064107 | 26,644,410 | 1,963,479 | SH | SOLE | 1,963,479 | 0 | 0 | |||
Affimed N.V. | COM | N01045108 | 2,126,007 | 4,448,644 | SH | SOLE | 4,448,644 | 0 | 0 | |||
Akero Therapeutics, Inc. | COM | 00973Y108 | 119,792,559 | 2,368,378 | SH | SOLE | 2,368,378 | 0 | 0 | |||
Alector, Inc. | COM | 014442107 | 6,252,234 | 964,851 | SH | SOLE | 964,851 | 0 | 0 | |||
Aligos Therapeutics, Inc. | COM | 01626L105 | 1,551,071 | 2,076,400 | SH | SOLE | 2,076,400 | 0 | 0 | |||
AnaptysBio, Inc. | COM | 032724106 | 1,907,298 | 106,197 | SH | SOLE | 106,197 | 0 | 0 | |||
argenx SE | SPONSORED ADR | 04016X101 | 74,341,830 | 151,215 | SH | SOLE | 151,215 | 0 | 0 | |||
ARS Pharmaceuticals, Inc. | COM | 82835W108 | 7,584,385 | 2,006,451 | SH | SOLE | 2,006,451 | 0 | 0 | |||
Arvinas, Inc. | COM | 04335A105 | 8,120,767 | 413,481 | SH | SOLE | 413,481 | 0 | 0 | |||
Athira Pharma, Inc. | COM | 04746L104 | 6,370,690 | 3,153,807 | SH | SOLE | 3,153,807 | 0 | 0 | |||
Atreca, Inc. | CL A COM | 04965G109 | 922,050 | 3,532,760 | SH | SOLE | 3,532,760 | 0 | 0 | |||
Avidity Biosciences, Inc. | COM | 05370A108 | 1,061,294 | 166,347 | SH | SOLE | 166,347 | 0 | 0 | |||
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 2,098,884,503 | 11,668,897 | SH | SOLE | 11,668,897 | 0 | 0 | |||
Bicycle Therapeutics plc | SPONSORED ADS | 088786108 | 16,952,223 | 843,814 | SH | SOLE | 843,814 | 0 | 0 | |||
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 89,992,591 | 12,710,818 | SH | SOLE | 12,710,818 | 0 | 0 | |||
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 337,130,743 | 3,810,248 | SH | SOLE | 3,810,248 | 0 | 0 | |||
Biomea Fusion, Inc. | COM | 09077A106 | 29,019,138 | 2,108,949 | SH | SOLE | 2,108,949 | 0 | 0 | |||
bluebird bio, Inc. | COM | 09609G100 | 7,599,134 | 2,499,715 | SH | SOLE | 2,499,715 | 0 | 0 | |||
Cabaletta Bio, Inc. | COM | 12674W109 | 24,260,680 | 1,594,000 | SH | SOLE | 1,594,000 | 0 | 0 | |||
Celcuity Inc. | COM | 15102K100 | 4,894,269 | 535,478 | SH | SOLE | 535,478 | 0 | 0 | |||
Century Therapeutics, Inc. | COM | 15673T100 | 2,298,680 | 1,149,340 | SH | SOLE | 1,149,340 | 0 | 0 | |||
Cerus Corporation | COM | 157085101 | 27,927,992 | 17,239,501 | SH | SOLE | 17,239,501 | 0 | 0 | |||
Cogent Biosciences, Inc. | COM | 19240Q201 | 12,606,419 | 1,292,966 | SH | SOLE | 1,292,966 | 0 | 0 | |||
Compass Therapeutics, Inc. | COM | 20454B104 | 3,068,531 | 1,557,630 | SH | SOLE | 1,557,630 | 0 | 0 | |||
Day One Biopharmaceuticals, Inc. | COM | 23954D109 | 12,270,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | |||
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 19,875,399 | 14,614,264 | SH | SOLE | 14,614,264 | 0 | 0 | |||
Denali Therapeutics Inc. | COM | 24823R105 | 47,284,022 | 2,292,003 | SH | SOLE | 2,292,003 | 0 | 0 | |||
Design Therapeutics, Inc. | COM | 25056L103 | 3,540,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | |||
Edgewise Therapeutics, Inc. | COM | 28036F105 | 6,014,775 | 1,049,699 | SH | SOLE | 1,049,699 | 0 | 0 | |||
Entrada Therapeutics, Inc. | COM | 29384C108 | 76,879,940 | 4,865,819 | SH | SOLE | 4,865,819 | 0 | 0 | |||
Foghorn Therapeutics Inc. | COM | 344174107 | 225,135 | 45,027 | SH | SOLE | 45,027 | 0 | 0 | |||
Genetron Holdings Limited | ADS | 37186H100 | 369,754 | 455,306 | SH | SOLE | 455,306 | 0 | 0 | |||
Geron Corporation | COM | 374163103 | 6,489,795 | 3,061,224 | SH | SOLE | 3,061,224 | 0 | 0 | |||
Gracell Biotechnologies Inc. | SPONSORED ADS | 38406L103 | 2,880,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | |||
Heron Therapeutics, Inc. | COM | 427746102 | 8,375,628 | 8,131,678 | SH | SOLE | 8,131,678 | 0 | 0 | |||
HOOKIPA Pharma Inc. | COM | 43906K100 | 4,968,285 | 8,065,398 | SH | SOLE | 8,065,398 | 0 | 0 | |||
IDEAYA Biosciences, Inc. | COM | 45166A102 | 28,656,079 | 1,062,123 | SH | SOLE | 1,062,123 | 0 | 0 | |||
IGM Biosciences, Inc. | COM | 449585108 | 26,367,329 | 3,157,764 | SH | SOLE | 3,157,764 | 0 | 0 | |||
Immatics N.V. | SHS | N44445109 | 65,320,649 | 5,640,816 | SH | SOLE | 5,640,816 | 0 | 0 | |||
Immunocore Holdings plc | ADS | 45258D105 | 130,825,939 | 2,520,731 | SH | SOLE | 2,520,731 | 0 | 0 | |||
Immunovant, Inc. | COM | 45258J102 | 16,316,096 | 425,009 | SH | SOLE | 425,009 | 0 | 0 | |||
Incyte Corporation | COM | 45337C102 | 2,090,035,758 | 36,178,566 | SH | SOLE | 36,178,566 | 0 | 0 | |||
Insmed Incorporated | COM PAR $.01 | 457669307 | 8,660,750 | 343,000 | SH | SOLE | 343,000 | 0 | 0 | |||
Instil Bio, Inc. | COM | 45783C101 | 2,013,481 | 4,704,395 | SH | SOLE | 4,704,395 | 0 | 0 | |||
Invitae Corporation | COM | 46185L103 | 1,067,903 | 1,764,546 | SH | SOLE | 1,764,546 | 0 | 0 | |||
iTeos Therapeutics, Inc. | COM | 46565G104 | 1,646,289 | 150,346 | SH | SOLE | 150,346 | 0 | 0 | |||
KALA BIO, Inc. | COM | 483119202 | 2,372,856 | 266,613 | SH | SOLE | 266,613 | 0 | 0 | |||
Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | 48,802,352 | 2,809,577 | SH | SOLE | 2,809,577 | 0 | 0 | |||
Kodiak Sciences Inc. | COM | 50015M109 | 31,158,882 | 17,310,490 | SH | SOLE | 17,310,490 | 0 | 0 | |||
Krystal Biotech, Inc. | COM | 501147102 | 19,712,344 | 169,934 | SH | SOLE | 169,934 | 0 | 0 | |||
Kymera Therapeutics, Inc. | COM | 501575104 | 66,030,560 | 4,750,400 | SH | SOLE | 4,750,400 | 0 | 0 | |||
Leap Therapeutics, Inc. | COM | 52187K200 | 1,617,602 | 1,172,175 | SH | SOLE | 1,172,175 | 0 | 0 | |||
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 225,648,303 | 1,545,113 | SH | SOLE | 1,545,113 | 0 | 0 | |||
Mersana Therapeutics, Inc. | COM | 59045L106 | 1,379,366 | 1,086,115 | SH | SOLE | 1,086,115 | 0 | 0 | |||
Mirati Therapeutics, Inc. | COM | 60468T105 | 61,410,191 | 1,409,784 | SH | SOLE | 1,409,784 | 0 | 0 | |||
Mirum Pharmaceuticals, Inc. | COM | 604749101 | 6,019,042 | 190,476 | SH | SOLE | 190,476 | 0 | 0 | |||
Monte Rosa Therapeutics, Inc. | COM | 61225M102 | 23,548,095 | 4,916,095 | SH | SOLE | 4,916,095 | 0 | 0 | |||
Morphic Holding, Inc. | COM | 61775R105 | 4,943,978 | 215,800 | SH | SOLE | 215,800 | 0 | 0 | |||
Natera, Inc. | COM | 632307104 | 4,425,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
Neoleukin Therapeutics, Inc. | COM | 64049K203 | 4,824,585 | 1,221,414 | SH | SOLE | 1,221,414 | 0 | 0 | |||
Nurix Therapeutics, Inc. | COM | 67080M103 | 30,513,503 | 3,882,125 | SH | SOLE | 3,882,125 | 0 | 0 | |||
Opthea Limited | SPONSORED ADS | 68386J208 | 4,687,532 | 2,690,891 | SH | SOLE | 2,690,891 | 0 | 0 | |||
Pacific Biosciences of California, Inc. | COM | 69404D108 | 9,416,980 | 1,127,782 | SH | SOLE | 1,127,782 | 0 | 0 | |||
Perspective Therapeutics, Inc. | COM | 46489V104 | 2,090,987 | 7,639,703 | SH | SOLE | 7,639,703 | 0 | 0 | |||
PMV Pharmaceuticals, Inc. | COM | 69353Y103 | 1,977,227 | 322,024 | SH | SOLE | 322,024 | 0 | 0 | |||
POINT Biopharma Global Inc. | COM | 730541109 | 1,667,287 | 249,968 | SH | SOLE | 249,968 | 0 | 0 | |||
Praxis Precision Medicines, Inc. | COM | 74006W108 | 3,214,655 | 1,879,915 | SH | SOLE | 1,879,915 | 0 | 0 | |||
Prelude Therapeutics Inc. | COM | 74065P101 | 31,282,616 | 10,123,824 | SH | SOLE | 10,123,824 | 0 | 0 | |||
Prime Medicine, Inc. | COM | 74168J101 | 9,811,566 | 1,028,466 | SH | SOLE | 1,028,466 | 0 | 0 | |||
Protara Therapeutics, Inc. | COM STK | 74365U107 | 333,451 | 199,671 | SH | SOLE | 199,671 | 0 | 0 | |||
Relay Therapeutics, Inc. | COM | 75943R102 | 9,756,584 | 1,160,117 | SH | SOLE | 1,160,117 | 0 | 0 | |||
Replimune Group, Inc. | COM | 76029N106 | 78,334,371 | 4,578,280 | SH | SOLE | 4,578,280 | 0 | 0 | |||
Revolution Medicines, Inc. | COM | 76155X100 | 74,500,526 | 2,691,493 | SH | SOLE | 2,691,493 | 0 | 0 | |||
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 153,651,351 | 6,702,349 | SH | SOLE | 6,702,349 | 0 | 0 | |||
Roivant Sciences Ltd. | SHS | G76279101 | 138,725,357 | 11,877,171 | SH | SOLE | 11,877,171 | 0 | 0 | |||
Sagimet Biosciences Inc. | COM | 786700104 | 7,175,159 | 815,359 | SH | SOLE | 815,359 | 0 | 0 | |||
Sana Biotechnology, Inc. | COM | 799566104 | 7,740,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | |||
Seagen Inc. | COM | 81181C104 | 9,452,165,468 | 44,554,162 | SH | SOLE | 44,554,162 | 0 | 0 | |||
Sera Prognostics, Inc. | CLASS A COM | 81749D107 | 2,818,536 | 1,515,342 | SH | SOLE | 1,515,342 | 0 | 0 | |||
SpringWorks Therapeutics, Inc. | COM | 85205L107 | 69,356,440 | 2,999,846 | SH | SOLE | 2,999,846 | 0 | 0 | |||
Stoke Therapeutics, Inc. | COM | 86150R107 | 5,854,505 | 1,485,915 | SH | SOLE | 1,485,915 | 0 | 0 | |||
Summit Therapeutics Inc. | COM | 86627T108 | 5,872,685 | 3,140,473 | SH | SOLE | 3,140,473 | 0 | 0 | |||
Surrozen, Inc. | W EXP 8/11/2026 | 86889P117 | 34,250 | 833,333 | SH | SOLE | 833,333 | 0 | 0 | |||
Talis Biomedical Corporation | COM | 87424L207 | 2,933,024 | 508,323 | SH | SOLE | 508,323 | 0 | 0 | |||
Tango Therapeutics, Inc. | COM | 87583X109 | 8,445,000 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | |||
Taysha Gene Therapies, Inc. | COM SHS | 877619106 | 7,915,029 | 2,504,756 | SH | SOLE | 2,504,756 | 0 | 0 | |||
TScan Therapeutics, Inc. | COM | 89854M101 | 7,129,068 | 2,784,792 | SH | SOLE | 2,784,792 | 0 | 0 | |||
Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | 48,717,401 | 1,366,547 | SH | SOLE | 1,366,547 | 0 | 0 | |||
Vaxcyte, Inc. | COM | 92243G108 | 2,492,157 | 48,885 | SH | SOLE | 48,885 | 0 | 0 | |||
Verve Therapeutics, Inc. | COM | 92539P101 | 18,783,188 | 1,416,530 | SH | SOLE | 1,416,530 | 0 | 0 | |||
Vor Biopharma Inc. | COM | 929033108 | 1,343,758 | 633,848 | SH | SOLE | 633,848 | 0 | 0 | |||
Xencor, Inc. | COM | 98401F105 | 2,481,009 | 123,127 | SH | SOLE | 123,127 | 0 | 0 | |||
Xenon Pharmaceuticals Inc. | COM | 98420N105 | 25,675,988 | 751,639 | SH | SOLE | 751,639 | 0 | 0 | |||
Invitae Corporation | Note 1.5% 4/1/2028 | 46185LAD5 | 130,372,500 | 300,000,000 | PRN | SOLE | 300,000,000 | 0 | 0 | |||
Invitae Corporation | Series A 4.5% 3/15/2028 | 46185LAH6 | 6,208,368 | 9,274,000 | PRN | SOLE | 9,274,000 | 0 | 0 |